HuGE Literature Finder
Records 1 - 11
| Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2021 (9): e11097.
Banawalikar N, Adiga S, Adiga U, Shenoy V, Kumari S, Shetty P, Shetty S, Sharmila K
| Influence of UGT2B7 and UGT1A6 polymorphisms on plasma concentration to dose ratio of valproic acid in Chinese epileptic children.
Xenobiotica; the fate of foreign compounds in biological systems 2021 May 1-22.
Du Zhaosong, Xu Hua, Zhao Peiwei, Wang Jing, Xu Qiong, Liu Maocha
| CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study.
Epilepsy research 2021 10 177 106786.
Mani Balachandran, Nair Pradeep Pankajakshan, Sekhar Anamika, Kamalanathan Sadishkumar, Narayan Sunil K, Kesavan Ramasa
| Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy.
Frontiers in pediatrics 2021 2 8 599044.
Xu Ze-Yue, Guo Hong-Li, Li Ling, Zhang Min, Jing Xia, Xu Ze-Jun, Qiu Jin-Chun, Lu Xiao-Peng, Ding Xuan-Sheng, Chen Feng, Xu Ji
| Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy.
Therapeutic drug monitoring 2020 Feb .
Zhao Mingming, Chen Yanan, Wang Minglu, Li Guofei, Zhao Lim
| Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
European journal of clinical pharmacology 2016 Nov .
Lu Yao, Fang Youxin, Wu Xunyi, Ma Chunlai, Wang Yue, Xu L
| The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach.
Molecular diagnosis & therapy 2013 Oct 17 (5): 5.
Munisamy M, Tripathi M, Behari M, Raghavan S, Jain DC, Ramanujam B, Arumugam K, Rajakannan T, Mallayasamy SR, Subbiah V
| Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.
European journal of clinical pharmacology 2012 Oct 68 (10): 1395-401.
Chu Xiao-Man, Zhang Li-Fang, Wang Guang-Ji, Zhang Shen-Ning, Zhou Jia-Hui, Hao Hai-Pi
| Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.
Drug metabolism and pharmacokinetics 2012 27 (5): 536-42.
Guo Yingjie, Hu Cheng, He Xiaojing, Qiu Feng, Zhao Lim
| [Effect of UGT1A6 genetic polymorphisms on the metabolism of sodium valproate].
Zhonghua yi xue za zhi 2007 Aug 87 (29): 2033-5.
Sun Yan-ping, Tan Lan, Wang Yan, Song Jing-h
| Prevalence of UGT1A6 polymorphisms in children with epilepsy on valproate monotherapy.
Neurology India 0 63 (1): 35-9.
Jain Puneet, Shastri Shivaram, Gulati Sheffali, Kaleekal Thomas, Kabra Madhulika, Gupta Neerja, Gupta Y K, Pandey Ravindra Moh
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: